# New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis

> **NCT02583152** · — · UNKNOWN · sponsor: **Manchester Royal Eye Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Mucopolysaccharidoses

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02583152
- **Lead sponsor:** Manchester Royal Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583152, "New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02583152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*